Clinical Public Databases in Hidradenitis Suppurativa: A Viewpoint (Preprint)
Interactive Journal of Medical Research,
Journal Year:
2025,
Volume and Issue:
14, P. e70282 - e70282
Published: Feb. 7, 2025
In
this
viewpoint,
we
argue
that
recent
studies
using
clinical
public
databases
have
revolutionized
our
understanding
of
hidradenitis
suppurativa
(HS),
a
chronic
inflammatory
skin
condition
with
significant
impacts
on
patients’
quality
life.
Our
key
messages
are
as
follows:
(1)
these
enable
large-scale
integrating
genetic,
epidemiological,
and
data,
providing
crucial
insights
into
HS’s
genetic
predispositions,
comorbidities,
treatment
outcomes;
(2)
findings
highlight
strong
component,
mutations
in
the
γ-secretase
complex
playing
role
HS
pathogenesis
shaping
targeted
therapies;
(3)
also
reveal
elevated
risks
for
comorbidities
like
obesity,
diabetes,
cardiovascular
disease,
systemic
inflammation
patients
HS,
diet-driven
pathways
potentially
exacerbating
disease
severity;
(4)
while
offer
unprecedented
research
opportunities,
limitations
such
data
representativeness
must
be
considered;
(5)
nonetheless,
their
benefits
outweigh
potential
drawbacks,
allowing
identification
rare
progression
patterns,
personalized
strategies;
(6)
increased
funding
is
to
harness
databases’
full
potential,
develop
therapies,
ultimately
improve
patient
outcomes.
As
impact
disproportionate
current
investments,
believe
advocating
more
resources
addressing
database
will
advancing
care.
Language: Английский
Evaluating the impact of high-dose vitamin D3, vitamin C, vitamin E, and zinc supplementation on inflammatory cytokines, lesion severity, and symptom management in hidradenitis suppurativa
Grace Herrick,
No information about this author
Sriya Kakarla,
No information about this author
Kelly Frasier
No information about this author
et al.
International Journal of Research in Dermatology,
Journal Year:
2025,
Volume and Issue:
11(2), P. 199 - 207
Published: Feb. 24, 2025
This
integrative,
holistic
review
critically
evaluates
the
impact
of
high-dose
vitamin
D3,
C,
E,
and
zinc
supplementation
on
inflammatory
cytokine
levels,
lesion
severity,
symptom
management
in
patients
with
hidradenitis
suppurativa
(HS).
By
integrating
data
from
recent
clinical
trials
observational
studies,
we
explore
how
these
supplements
influence
key
aspects
HS
pathology.
High-dose
D3
has
been
shown
to
significantly
reduce
levels
cytokines
decrease
suggesting
its
role
modulating
immune
responses
improving
disease
outcomes.
Similarly,
antioxidant
properties
vitamins
C
E
are
assessed
for
their
ability
oxidative
stress
inflammation,
which
may
lead
improved
reduced
severity
lesions.
Zinc
supplementation,
particularly
form
sulfate,
is
examined
effects
enhancing
skin
barrier
function
decreasing
frequency
flares.
Collectively,
nutritional
interventions
offer
a
multifaceted
approach
management,
highlighting
potential
combining
optimize
therapeutic
The
findings
underscore
need
further
research
determine
optimal
dosing,
duration,
interaction
standard
treatments
establish
comprehensive
protocols.
Language: Английский
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature
Clinical Cosmetic and Investigational Dermatology,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 617 - 626
Published: March 1, 2025
This
systematic
review
explores
the
increased
cancer
risk
in
patients
with
hidradenitis
suppurativa
(HS),
particularly
cutaneous
squamous
cell
carcinoma
(SCC)
and
lymphoma.
Chronic
inflammation
immune
dysregulation
HS
are
identified
as
key
factors
contributing
to
malignant
transformation,
often
observed
areas
of
prolonged
tissue
damage.
The
NOTCH
signaling
pathway,
disrupted
by
smoking,
plays
a
dual
role
cancer,
acting
both
tumor
suppressor
proto-oncogene
depending
on
context.
Mutations
TP53
common
SCC
linked
HS,
prevalence
0.5%
4.6%,
predominantly
men
localized
buttock
anogenital
regions.
Histological
analyses
suggest
that
transformation
occurs
within
keratinized
epithelium,
supported
altered
cytokeratin
expression.
Immune
HS-affected
areas,
compounded
scarring
lymphatic
disruption,
further
exacerbates
tumorigenic
potential.
While
anti-TNF-alpha
therapies
have
been
implicated
risk,
conflicting
evidence
meta-analyses
no
consistent
increase
non-melanoma
skin
cancers
(NMSC).
Similarly,
IL-17
inhibitors
show
potential
risks
but
lack
robust
HS-specific
populations.
In
conclusion,
HS-associated
malignancies,
SCC,
underscore
need
for
research
elucidate
mechanisms
linking
chronic
development.
Insights
from
such
studies
could
guide
preventative
therapeutic
strategies,
improving
outcomes
patients.
Language: Английский
Evaluation of the Psychosocial Burden of Hidradenitis Suppurativa and Relevant Factors: A Prospective Single-Center Study
İlknur Kıvanç Altunay,
No information about this author
Cemre Akpulat Tekin,
No information about this author
Sena Inal Aptoula
No information about this author
et al.
SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital,
Journal Year:
2025,
Volume and Issue:
unknown, P. 28 - 34
Published: Jan. 1, 2025
Hidradenitis
suppurativa
(HS)
is
a
chronic
inflammatory
skin
disorder
in
which
patients
with
HS
experience
profound
deterioration
their
overall
well-being,
psychological
state
and
quality
of
life.
This
study
aimed
to
evaluate
the
impact
examined
its
associations
relevant
factors,
including
sociodemographic
disease-related
characteristics.
A
prospective,
single-center
was
conducted
involving
80
HS.
The
demographic
clinical
characteristics
were
recorded.
Depression
Anxiety
Stress
Scale-21
(DASS-21),
Dermatology
Life
Quality
Index
(DLQI),
General
Health
Questionnaire-12
(GHQ-12)
used
assess
psychosocial
significant
proportion
had
severe
extremely
scores
depression,
anxiety
stress,
48.75%,
52.5%,
48.75%
patients,
respectively.
Sixty
percent
exhibited
high
disorders
while
53.8%
experienced
impairment
life
(QoL).
Sociodemographic
factors
evaluated
for
scales
this
study.
DASS-21
(DASS-21A)
significantly
positively
correlated
lower
education
levels
higher
body
mass
index
(BMI)
(p<0.05).
There
no
correlations
between
Hurley
stages
other
three
scales,
except
(DASS-21S)
subscale.
Patients
family
history
DASS-21A,
(DASS-21D),
DASS-21S,
GHQ-12
(both
Likert
traditional
scoring)
compared
those
without
Additionally,
positive
predicted
on
DASS-21D,
DASS-21S
(p=0.002;
p=0.019;
p=0.022,
respectively).
Our
findings
confirm
that
or
all
assessing
burden
negatively
affected
psychologically
at
each
stage.
Family
proved
be
strong
predictive
factor
contributing
impaired
status
among
individuals
Thus,
dermatologists
should
provide
extra
care,
especially
members
by
condition.
Language: Английский
Hidradenite supurativa: uma revisão da literatura
Gabrielle Santiago Silva,
No information about this author
Gessica Bazani Gloria,
No information about this author
Ana Luiza Parente Cavalcanti
No information about this author
et al.
Journal Archives of Health,
Journal Year:
2024,
Volume and Issue:
5(3), P. e2024 - e2024
Published: July 30, 2024
A
hidradenite
supurativa
(HS)
é
uma
condição
médica
marcada
por
inflamação
crônica
causada
pela
obstrução
dos
folículos
pilosos.
Geralmente,
esta
doença
afeta
regiões
da
pele
sujeitas
a
atrito,
como
axilas,
virilha
e
nádegas.
Os
sintomas
comuns
incluem
nódulos
dolorosos
sob
pele,
abscessos,
cicatrizes
secreção
de
pus.
O
tratamento
envolve
combinação
antibióticos,
anti-inflamatórios
mudanças
no
estilo
vida,
boa
higiene.
presente
artigo
revisa
causa
doença,
destaca
os
opções
tratamento,
com
foco
nos
estágios
gravidade
acordo
classificação
Hurley,
visando
fornecer
aos
profissionais
saúde
o
conhecimento
necessário
para
gerenciar
pacientes
essa
condição.
Targeted Therapy Outcomes in Hidradenitis Suppurativa: A Systematic Review
Chenxingyue Zhang,
No information about this author
Xinyi Dai,
No information about this author
Zhiqiang Yin
No information about this author
et al.
American Journal of Therapeutics,
Journal Year:
2024,
Volume and Issue:
32(1), P. e114 - e116
Published: Oct. 25, 2024
Language: Английский
Increased risk of migraine among patients with hidradenitis suppurativa: A US multi-center cohort study
Shuo‐Yan Gau,
No information about this author
Shao-Wei Lo,
No information about this author
Tsu‐Man Chiu
No information about this author
et al.
Biomedical Journal,
Journal Year:
2024,
Volume and Issue:
unknown, P. 100816 - 100816
Published: Nov. 1, 2024
Language: Английский
hUC-MSC extracellular vesicles protect against hypoxic-ischemic brain injury by promoting NLRP3 ubiquitination
Shanshan Xiao,
No information about this author
Ying Lv,
No information about this author
Xiaojie Hou
No information about this author
et al.
Biomolecules and Biomedicine,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 26, 2024
Hypoxic-ischemic
brain
injury
(HIBD)
is
a
major
cause
of
neonatal
mortality
and
long-term
neurological
deficits,
with
limited
treatment
options.
Extracellular
vesicles
(EVs)
from
human
umbilical
cord
mesenchymal
stem
cells
(hUC-MSC-EVs)
have
shown
promise
in
neuroprotection,
but
the
mechanisms
remain
unclear.
This
study
explores
how
hUC-MSC-EVs
protect
rats
HIBD.
were
isolated,
characterized,
administered
to
subjected
Behavioral
reflexes
infarction
assessed,
along
cellular
molecular
analyses
hippocampal
tissue.
An
vitro
oxygen–glucose
deprivation/reoxygenation
(OGD/R)
model
was
used
simulate
ischemic
conditions
rat
primary
microglia.
Results
demonstrated
that
significantly
improved
outcomes,
reduced
infarction,
decreased
microglial
activation
pyroptosis.
These
effects
linked
inhibition
NLRP3
inflammasome
enhanced
ubiquitination
via
protein
kinase
A
(PKA)
pathway.
Blocking
PKA
partially
reversed
these
protective
effects.
Here
we
highlight
provide
neuroprotection
by
regulating
inflammasome,
offering
potential
therapeutic
strategy
for
findings
expand
understanding
EV-mediated
suggest
broader
applications
ischemia-related
conditions,
clinical
translation.
Language: Английский